FDA advances drug repurposing to address unmet medical needs

FDA

11 May 2026 - Agency is particularly focused on new uses to treat chronic or rare diseases.

The US FDA today announced it is soliciting input on efforts with respect to drug repurposing to help address unmet medical needs across a range of diseases and conditions.

Read FDA press release 

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Innovation